万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生2>>护理
您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生1>>儿科
您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生1>>妇产科学

JOURNAL OF HUMAN LACTATION《人类哺乳杂志》 (官网投稿)

简介
  • 期刊简称J HUM LACT
  • 参考译名《人类哺乳杂志》
  • 核心类别 SCIE(2024版), 目次收录(维普),外文期刊,
  • IF影响因子
  • 自引率16.00%
  • 主要研究方向医学-NURSING 护理;OBSTETRICS & GYNECOLOGY 妇产科学;PEDIATRICS 儿科

主要研究方向:

等待设置主要研究方向
医学-NURSING 护理;OBSTETRICS & GYNECOLOGY 妇产科学;PEDIATRICS 儿科

JOURNAL OF HUMAN LACTATION《人类哺乳杂志》(季刊). Journal of Human Lactation (JHL) is an international multi-disciplinary quarterly, peer-reviewed journal&...[显示全部]
征稿信息

万维提示:

1、投稿方式:在线投稿

2期刊网址:https://journals.sagepub.com/home/JHL

3投稿网址:https://mc.manuscriptcentral.com/jhl

4、官网邮箱:jhleditorinchief@gmail.com(主编)

5、期刊刊期:季刊,逢季中月出版。

2021年8月18日星期

                                 

 

投稿须知【官网信息】

 

Manuscript Submission Guidelines:

Please read the following materials, which apply to all manuscripts and include general policies and publications standards.

At the end of the general directions, there will be a list of manuscript types. These links will lead you to specific directions for the manuscript type that you are preparing.

JHL PUBLISHING POLICIES FOR ALL MANUSCRIPT SUBMISSIONS

As a member of the Committee on Publication Ethics (COPE), the Journal of Human Lactation follows their ethical guidance, as well as the ethical standards set forth by other recognized international publications standards.

Protection of Human Rights

JHL only publishes research that has been conducted ethically. All researchers must state within their manuscripts that investigations were carried out using a high ethical standard. Evidence of protection of human subjects’ rights approved by an appropriately credentialed Institutional Review Board is required for all research manuscripts, with the exception of literature reviews (document in the Design sub-section of Methods section). The specifics about how informed consent was obtained should be described in the Data Collection section of the submitted manuscript. All experimental studies must conform to the Declaration of Helsinki (World Medical Association, 2001).

Authors are required to ensure the following guidelines are followed, as per the International Committee of Medical Journal Editors recommendations (Fees, 2015):

Participants have a right to privacy, which should not be infringed upon without their informed consent.

Identifying information, including participants’ names, initials, or hospital numbers should not be published in written descriptions, photographs, or pedigrees unless the information is essential for scientific purposes and the participant (or parent or guardian) has given written informed consent for publication. Informed consent in this situation requires that an identifiable participant be shown the manuscript and provide consent prior to submission.

Identifying details should be omitted if they are not essential. Complete anonymity is difficult to achieve; therefore, informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of participants is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity (e.g., in genetic pedigrees), authors should provide assurance that alterations do not distort scientific meaning.

Peer review policy

All manuscripts are reviewed initially by the editors and only those papers that meet the scientific and editorial standards of the journal, as well as fit within the aims and scope of the journal are considered for publication. JHL operates a conventional double-blind peer review for all original research, original perspectives, and Insights into Policy and Practice manuscripts. During this process both the reviewers’ and authors’ names (as well as any other identifying information) are concealed. Other types of submissions (e.g., letters to the Editor, organizational news briefs, commentaries, book reviews, Lactation Newsmakers, and About Research features) are peer reviewed but not blinded. Each research manuscript is reviewed by 2 or 3 peer reviewers and an Associate Editor during the manuscript review process. All manuscripts are reviewed as soon as possible, and an editorial decision is generally reached within eight weeks of submission. However, in some cases more than 8 weeks may be needed to ensure quality and rigor of a manuscript.

The Editor in Chief makes all final decisions about publication and has broad discretion in determining whether an article is an appropriate fit for the journal. Many manuscripts are declined with a very general statement of the rejection decision. These decisions are not eligible for appeal unless the author believes the decision to reject the manuscript was based on an error in the review of the article or that ethical misconduct occurred. In this case the author may appeal the decision by providing the Editor in Chief (jhleditorinchief@gmail.com) with a detailed written description of the error or ethical misconduct they believe occurred. If an author believes the decision regarding their manuscript was affected by a publication ethics breach, the author also may contact the publisher with a detailed written description of their concern, and information supporting the concern, at publication_ethics@sagepub.com.

JHL editors and staff are permitted to submit papers to the journal for consideration. In this scenario, the author-editor is excluded from all information about peer review and editorial decision-making processes. The peer review process remains double-blinded, as it is for all authors.  The manuscript is processed entirely by other members of the editorial staff and the editor-author is notified of decisions in the same way as are all other authors. These manuscripts are held to the same standards and processes as are all other submissions. If accepted and published, these articles will have an Editor’s note confirming the above process was followed.

……

更多详情:

https://journals.sagepub.com/author-instructions/JHL


  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文投稿平台    E-mail:eshukan@163.com


投稿问答最小化  关闭